438 related articles for article (PubMed ID: 34512363)
1. MicroRNA as an Important Target for Anticancer Drug Development.
Fu Z; Wang L; Li S; Chen F; Au-Yeung KK; Shi C
Front Pharmacol; 2021; 12():736323. PubMed ID: 34512363
[TBL] [Abstract][Full Text] [Related]
2. Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update.
Bayraktar E; Bayraktar R; Oztatlici H; Lopez-Berestein G; Amero P; Rodriguez-Aguayo C
Noncoding RNA; 2023 Apr; 9(2):. PubMed ID: 37104009
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-based therapeutics for cancer.
Wang V; Wu W
BioDrugs; 2009; 23(1):15-23. PubMed ID: 19344188
[TBL] [Abstract][Full Text] [Related]
4. MiRNA as a Potential Target for Multiple Myeloma Therapy-Current Knowledge and Perspectives.
Szudy-Szczyrek A; Ahern S; Krawczyk J; Szczyrek M; Hus M
J Pers Med; 2022 Aug; 12(9):. PubMed ID: 36143213
[TBL] [Abstract][Full Text] [Related]
5. Advances in the discovery of microRNA-based anticancer therapeutics: latest tools and developments.
To KKW; Fong W; Tong CWS; Wu M; Yan W; Cho WCS
Expert Opin Drug Discov; 2020 Jan; 15(1):63-83. PubMed ID: 31739699
[No Abstract] [Full Text] [Related]
6. MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment.
Kaboli PJ; Rahmat A; Ismail P; Ling KH
Pharmacol Res; 2015 Jul; 97():104-21. PubMed ID: 25958353
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Targeting of microRNAs in Cancer: Future Perspectives.
Tutar L; Tutar E; Özgür A; Tutar Y
Drug Dev Res; 2015 Nov; 76(7):382-8. PubMed ID: 26435382
[TBL] [Abstract][Full Text] [Related]
8. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA: Promising Roles in Cancer Therapy.
Hashemi A; Gorji-Bahri G
Curr Pharm Biotechnol; 2020; 21(12):1186-1203. PubMed ID: 32310047
[TBL] [Abstract][Full Text] [Related]
10. microRNAs as oncogenes and tumor suppressors.
Zhang B; Pan X; Cobb GP; Anderson TA
Dev Biol; 2007 Feb; 302(1):1-12. PubMed ID: 16989803
[TBL] [Abstract][Full Text] [Related]
11. Emerging roles for modulation of microRNA signatures in cancer chemoprevention.
Neelakandan K; Babu P; Nair S
Curr Cancer Drug Targets; 2012 Jul; 12(6):716-40. PubMed ID: 22515522
[TBL] [Abstract][Full Text] [Related]
12. Modulation of microRNAs for potential cancer therapeutics.
Wu W
Methods Mol Biol; 2011; 676():59-70. PubMed ID: 20931390
[TBL] [Abstract][Full Text] [Related]
13. Expression profile of MicroRNA: An Emerging Hallmark of Cancer.
Zaheer U; Faheem M; Qadri I; Begum N; Yassine HM; Al Thani AA; Mathew S
Curr Pharm Des; 2019; 25(6):642-653. PubMed ID: 30914015
[TBL] [Abstract][Full Text] [Related]
14. Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review).
Gambari R; Brognara E; Spandidos DA; Fabbri E
Int J Oncol; 2016 Jul; 49(1):5-32. PubMed ID: 27175518
[TBL] [Abstract][Full Text] [Related]
15. Gold Nanoconjugates for miRNA Modulation in Cancer Therapy: From miRNA Silencing to miRNA Mimics.
Sousa DP; Conde J
ACS Mater Au; 2022 Nov; 2(6):626-640. PubMed ID: 36397876
[TBL] [Abstract][Full Text] [Related]
16. Novel approaches in cancer treatment: preclinical and clinical development of small non-coding RNA therapeutics.
Cuciniello R; Filosa S; Crispi S
J Exp Clin Cancer Res; 2021 Dec; 40(1):383. PubMed ID: 34863235
[TBL] [Abstract][Full Text] [Related]
17. miRNAs in Melanoma: Tumor Suppressors and Oncogenes with Prognostic Potential.
Wozniak M; Mielczarek A; Czyz M
Curr Med Chem; 2016; 23(28):3136-3153. PubMed ID: 27666934
[TBL] [Abstract][Full Text] [Related]
18. A step-by-step microRNA guide to cancer development and metastasis.
Markopoulos GS; Roupakia E; Tokamani M; Chavdoula E; Hatziapostolou M; Polytarchou C; Marcu KB; Papavassiliou AG; Sandaltzopoulos R; Kolettas E
Cell Oncol (Dordr); 2017 Aug; 40(4):303-339. PubMed ID: 28748501
[TBL] [Abstract][Full Text] [Related]
19. Systems biology-based investigation of cooperating microRNAs as monotherapy or adjuvant therapy in cancer.
Lai X; Eberhardt M; Schmitz U; Vera J
Nucleic Acids Res; 2019 Sep; 47(15):7753-7766. PubMed ID: 31340025
[TBL] [Abstract][Full Text] [Related]
20. Circulating microRNAs as Potential Biomarkers in Pancreatic Cancer-Advances and Challenges.
Seyhan AA
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
